Neuland Laboratories Limited — Year ended March 31, 2026 (quarter ended March 31, 2026 also disclosed)
| Sl. No. | Particulars | Quarter Ended 31.03.2026 (Audited) Refer Note 9 | Quarter Ended 31.12.2025 (Unaudited) | Quarter Ended 31.03.2025 (Audited) Refer Note 9 | Year Ended 31.03.2026 (Audited) | Year Ended 31.03.2025 (Audited) |
|---|---|---|---|---|---|---|
| 1 | Income | |||||
| (a) Revenue from operations | 77,625.03 | 43,970.93 | 32,836.00 | 2,02,298.54 | 1,47,683.73 | |
| (b) Other income | 1,245.82 | 805.24 | 746.43 | 3,016.62 | 2,050.93 | |
| Total Income | 78,870.85 | 44,776.17 | 33,582.43 | 2,05,315.16 | 1,49,734.66 | |
| 2 | Expenses | |||||
| (a) Cost of materials consumed | 23,078.87 | 19,985.54 | 14,124.15 | 81,976.45 | 57,480.68 | |
| (b) Changes in inventories of finished goods and work-in-progress | 3,850.21 | (1,079.69) | (1,434.14) | (6,426.23) | 1,283.12 | |
| (c) Employee benefits expense | 9,847.17 | 8,883.23 | 6,645.75 | 34,114.14 | 27,200.48 | |
| (d) Finance costs | 720.51 | 679.03 | 234.67 | 2,394.74 | 829.71 | |
| (e) Depreciation and amortisation expenses | 2,508.89 | 2,391.96 | 1,689.19 | 9,173.95 | 6,554.66 | |
| (f) Manufacturing expenses | 5,172.22 | 5,456.12 | 4,509.03 | 19,161.44 | 16,287.00 | |
| (g) Other expenses | 4,943.50 | 3,012.44 | 3,883.82 | 16,022.96 | 13,106.47 | |
| Total expenses | 50,121.37 | 39,328.63 | 29,652.47 | 1,56,417.45 | 1,22,742.12 | |
| 3 | Profit before exceptional item and tax (1-2) | 28,749.48 | 5,447.54 | 3,929.96 | 48,897.71 | 26,992.54 |
| 4 | Exceptional item (Refer Note 5) | – | – | – | – | 7,640.36 |
| 5 | Profit before tax (3+4) | 28,749.48 | 5,447.54 | 3,929.96 | 48,897.71 | 34,632.90 |
| 6 | Tax expense | |||||
| (a) Current tax | 7,682.21 | 1,525.40 | 602.33 | 12,895.54 | 7,376.68 | |
| (b) Deferred tax (credit)/charge | (199.99) | (135.05) | 547.04 | (397.67) | 1,245.41 | |
| 7 | Profit for the period / year (5-6) | 21,267.26 | 4,057.19 | 2,780.59 | 36,399.84 | 26,010.81 |
| 8 | Other comprehensive income/(loss) (net of taxes) | |||||
| (a) Items that will not be reclassified to profit or loss | ||||||
| Re-measurement gain/(loss) on defined benefit plans | 65.65 | (24.89) | (3.22) | 1.65 | (56.30) | |
| Changes in fair value of equity instruments through other comprehensive income | 45.33 | – | 26.63 | 45.33 | 27.99 | |
| Tax on items that will not be reclassified to profit or loss | (27.93) | 6.27 | (5.90) | (11.82) | 7.12 | |
| (b) Items that will be reclassified to profit or loss | ||||||
| Exchange differences in translating the financial statements of foreign operations | 40.61 | 2.28 | 2.85 | 71.25 | 16.71 | |
| Total comprehensive income | 21,390.92 | 4,040.85 | 2,800.95 | 36,506.25 | 26,006.33 | |
| 9 | Paid-up Equity Share Capital (Face value – ₹10 each) | 1,290.05 | 1,290.05 | 1,290.05 | 1,290.05 | 1,290.05 |
| 10 | Other equity (excluding revaluation reserve) | – | – | – | 1,86,073.35 | 1,51,106.69 |
| 11 | Earnings Per Share (of ₹10 each) (In absolute ₹ terms) | |||||
| Basic and Diluted (Refer Note 7) | 165.76 | 31.62 | 21.67 | 283.71 | 202.74 |
| Particulars | Quarter Ended 31.03.2026 (Audited) | 31.12.2025 (Unaudited) | 31.03.2025 (Audited) | Year Ended 31.03.2026 (Audited) | 31.03.2025 (Audited) |
|---|---|---|---|---|---|
| Segment Revenue | |||||
| India | 12,150.46 | 9,159.00 | 10,062.43 | 48,409.19 | 47,563.99 |
| Europe | 29,661.19 | 12,198.98 | 9,495.65 | 67,544.32 | 42,909.39 |
| USA and North America | 31,366.44 | 19,180.36 | 9,963.45 | 71,345.10 | 42,213.05 |
| Rest of the world | 4,446.94 | 3,432.59 | 3,314.47 | 14,999.93 | 14,997.30 |
| Revenue from Operations | 77,625.03 | 43,970.93 | 32,836.00 | 2,02,298.54 | 1,47,683.73 |
| Particulars | As At 31.03.2026 | As At 31.03.2025 |
|---|---|---|
| Segment Non-current assets | ||
| India | 1,43,305.04 | 1,02,947.67 |
| USA and North America | – | – |
| Rest of the world | 2.82 | 2.75 |
| Total | 1,43,307.86 | 1,02,950.42 |
| Particulars | 31.03.2026 (Audited) | 31.03.2025 (Audited) |
|---|---|---|
| ASSETS | ||
| Non-current assets | ||
| Property, plant and equipment | 79,341.51 | 65,373.07 |
| Right-of-use assets | 9,887.25 | 1,998.28 |
| Capital work-in-progress | 20,949.90 | 4,455.29 |
| Goodwill | 27,946.10 | 27,946.10 |
| Other intangible assets | 518.12 | 174.32 |
| Intangible assets under development | 108.46 | 311.08 |
| Financial assets | ||
| (i) Investments | 198.22 | 152.89 |
| (ii) Other financial assets | 1,194.81 | 935.16 |
| Income tax assets (net) | 396.27 | 1,132.33 |
| Other non-current assets | 4,160.25 | 1,559.95 |
| Total non-current assets | 1,44,700.89 | 1,04,038.47 |
| Current assets | ||
| Inventories | 51,028.64 | 38,575.69 |
| Financial assets | ||
| (i) Investments | – | 10,768.27 |
| (ii) Trade receivables | 54,135.31 | 31,572.06 |
| (iii) Cash and cash equivalents | 7,667.04 | 13,193.04 |
| (iv) Bank balances other than cash and cash equivalents | 27,829.45 | 12,688.86 |
| (v) Other financial assets | 433.81 | 221.56 |
| Other current assets | 7,218.63 | 6,930.21 |
| Total current assets | 1,48,312.88 | 1,13,949.69 |
| Total assets | 2,93,013.77 | 2,17,988.16 |
| EQUITY AND LIABILITIES | ||
| Equity | ||
| Equity share capital | 1,290.05 | 1,290.05 |
| Other equity | 1,86,157.24 | 1,51,190.58 |
| Total equity | 1,87,447.29 | 1,52,480.63 |
| Liabilities | ||
| Non-current liabilities | ||
| Financial liabilities | ||
| (i) Borrowings | 16,094.73 | 9,072.74 |
| (ia) Lease liabilities | 9,969.48 | 1,861.76 |
| Provisions | 1,586.11 | 722.23 |
| Deferred tax liabilities (net) | 6,896.36 | 7,282.21 |
| Total non-current liabilities | 34,546.68 | 18,938.94 |
| Current liabilities | ||
| Financial liabilities | ||
| (i) Borrowings | 3,566.58 | 4,528.27 |
| (ia) Lease liabilities | 496.43 | 250.99 |
| (ii) Trade payables | ||
| – total outstanding dues of micro enterprises and small enterprises | 1,264.29 | 843.04 |
| – total outstanding dues of creditors other than micro enterprises and small enterprises | 25,650.12 | 24,377.32 |
| (iii) Other financial liabilities | 12,678.26 | 8,454.70 |
| Provisions | 230.78 | 209.72 |
| Other current liabilities | 25,317.78 | 7,895.70 |
| Current tax liabilities (net) | 1,815.56 | 8.85 |
| Total current liabilities | 71,019.80 | 46,568.59 |
| Total liabilities | 1,05,566.48 | 65,507.53 |
| Total equity and liabilities | 2,93,013.77 | 2,17,988.16 |
| Particulars | Year Ended 31.03.2026 (Audited) | Year Ended 31.03.2025 (Audited) |
|---|---|---|
| Cash flow from operating activities | ||
| Profit before tax | 48,897.71 | 34,632.90 |
| Adjustments to reconcile profit before tax to net cash flow: | ||
| – Depreciation and amortisation expenses | 9,173.95 | 6,554.66 |
| – Interest income | (1,005.54) | (1,058.40) |
| – Loss on sale of property, plant and equipment, net | 527.38 | 731.06 |
| – Gain on sale of investment properties (Exceptional item) | – | (7,640.36) |
| – Finance costs | 2,394.74 | 829.71 |
| – Provision towards/(written back) credit impaired trade receivables | (204.67) | 170.06 |
| – Gain on redemption of investments carried at FVTPL | (755.47) | – |
| – Gain on fair valuation of investments carried at FVTPL | – | (768.27) |
| – Unrealised foreign exchange loss/(gain), net | 134.95 | (16.81) |
| Operating cash flows before working capital changes | 59,163.05 | 33,434.55 |
| Movements in working capital: | ||
| – Adjustments for (increase)/decrease in operating assets: | ||
| — Inventories | (12,452.95) | (3,533.50) |
| — Trade receivables | (22,421.18) | 5,490.67 |
| — Other financial assets | (789.14) | 62.52 |
| — Other assets | (282.96) | 838.04 |
| – Adjustments for increase/(decrease) in operating liabilities: | ||
| — Trade payables | 1,614.91 | 5,875.67 |
| — Other financial liabilities | 1,910.69 | (2,285.13) |
| — Provisions | 886.58 | (48.92) |
| — Other liabilities | 17,391.81 | (620.86) |
| Cash generated from operating activities | 45,020.81 | 39,213.04 |
| Income-taxes paid (net) | (10,352.77) | (7,472.62) |
| Net cash flow from operating activities (A) | 34,668.04 | 31,740.42 |
| Cash flows from investing activities | ||
| Purchase of property, plant and equipment and other intangible assets | (39,713.21) | (20,646.40) |
| Proceeds from sale of investments property | – | 9,543.13 |
| Proceeds from sale of property, plant and equipment | 92.63 | 116.42 |
| Proceeds from sale/redemption of current investments | 26,523.74 | – |
| Purchase of current investments | (15,000.00) | (10,000.00) |
| Proceeds from redemption/sale of non-current investments (net) | – | 2.97 |
| Movement in other bank balances (net) | (15,137.19) | (9,760.76) |
| Interest income received | 860.74 | 929.05 |
| Net cash used in investing activities (B) | (42,373.29) | (29,815.59) |
| Cash flows from financing activities | ||
| Proceeds from non-current borrowings | 10,560.93 | 9,477.82 |
| Repayment of non-current borrowings | (4,471.78) | (3,943.53) |
| Finance cost paid | (1,704.26) | (700.28) |
| Dividend paid | (1,539.59) | (1,796.18) |
| Payment of lease liabilities | (52.57) | (404.05) |
| Interest on lease liabilities | (695.19) | (137.68) |
| Net cash flow from financing activities (C) | 2,097.54 | 2,496.10 |
| Net (decrease)/ increase in cash and cash equivalents during the year (A + B + C) | (5,607.71) | 4,420.93 |
| Cash and cash equivalents at the beginning of the year | 13,193.04 | 8,757.54 |
| Effect of exchange rate changes on cash and cash equivalents | 81.71 | 14.57 |
| Cash and cash equivalents at the end of the year | 7,667.04 | 13,193.04 |
| Sl. No. | Particulars | Quarter Ended 31.03.2026 (Audited) Refer Note 8 | Quarter Ended 31.12.2025 (Unaudited) | Quarter Ended 31.03.2025 (Audited) Refer Note 8 | Year Ended 31.03.2026 (Audited) | Year Ended 31.03.2025 (Audited) |
|—|—|—: